Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4 Neoplasm Metastasis 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Ovarian Neoplasms 2 Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Brain Neoplasms 2 Vaping 1 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Neoplasms by Histologic Type 1 NSCLC 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 Hematologic Diseases 1

Interventions

orteronel 1 Nivolumab 1 Ketoconazole 1 BID protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Granulosa Cell Tumor × BID protein, human × Clear all

NCT02101684 2018-03-05

Greko II

Grupo Español de Tumores Huérfanos e Infrecuentes

Phase 2 Terminated

Granulosa Cell Tumor, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡